QTMeds

Drug Database Monograph

OMLYCLO 150 mg

PENDING REVIEW

Active Ingredient: OMALIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 69603381

← Back to Prescription Analyzer